Prognosis and Long Term Pubertal Outcome of Girls Previously Diagnosed With a Prenatal Ovarian Cyst

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

105 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-11-24

Study Completion Date

2025-05-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Puberty and long-term ovarian function of patients with a ovarian prenatal cyst has not described to date.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Role of Pre-natal Ultrasound in Predicting Outcomes of Fetal Ovarian Cysts

NCT06795685

Fetal Ovarian Cyst

COMPLETED

Monitoring Ovarian Cysts in Pregnancy

NCT03440931

Ovarian Cysts

UNKNOWN

Effect of Fetal Ovarian Cyst Aspiration to Prevent Torsion

NCT00222066

Ovarian Cyst Ultrasonography Prenatal

COMPLETED NA

Diagnostic Accuracy of Ultrasound and Tumors Markers in Diagnosis of Complex Ovarian Cysts

NCT07005089

Complex Ovarian Cyst

COMPLETED NA

Prevalence of Congenital Uterine Malformations

NCT01487616

Congenital Uterine Anomalies

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The prenatal diagnosis of ovarian cysts is a common disease with an estimated incidence of 1 case per 2500 births. This pathology is the first diagnosis of abdominal cystic picture on the female fetus in the third trimester of pregnancy.Various complications of ovarian cysts have been described, such as ovarian torsion, breaking the cyst, hemorrhage intra cystic and compression of adjacent viscera. A conservative attitude for uncomplicated cysts is proposed in the literature but surgical care and / or puncture can be made to prevent the occurrence of complications and thus to protect ovarian tissue.However, no data on puberty and long-term ovarian prognosis in this disease is published in the literature. Without this information, no support for the recommendation of a prenatal ovarian cyst can be established formally.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ovarian Cyst

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cases

Prenatal diagnosis of ovarian cyst

Group Type OTHER

Hormonal analysis, pelvic US

Intervention Type OTHER

controls

No prenatal diagnosis of cyst

Group Type OTHER

Hormonal analysis, pelvic US

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hormonal analysis, pelvic US

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Collection of the written consent by the patients or the parents
* Membership in a health insurance scheme
* Group 1 : girl with prenatal ovarian cyst group 2: girl without prenatal ovarian cyst

Exclusion Criteria

* Refusal of participation of the patient or one of the two parents
* Deprived of freedom
* Pregnancy and current feeding
* Prenatal, neonatal or infantile history of ovarian pathology (Group 2)
* Genital congenital deformation or malformation syndrome gives a complex (group 2)
* Endocrine pathology except the juvenile disorders (group 2)

Minimum Eligible Age

6 Years

Maximum Eligible Age

24 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes